16 results · 24ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

CoolSeal Trinity (30 cm shaft), CoolSeal Trinity (37 cm shaft), CoolSeal Trinity (44 cm shaft)

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

LYPHOCHEK TUMOR MARKER CONTROL, LEVELS 1 AND 2, 2ML, MODEL 580

FDA 510(k)
FDA Class 1 ·Clinical Chemistry

EK DELIVERY DEVICE

FDA 510(k)
FDA Class 1 ·Ophthalmic

OMNIPOD 5 POD

FDA Adverse Event
Malfunction ·INSULET CORPORATION·Product code QFG·June 1, 2023

OMNIPOD DASH INSULIN MANAGEMENT SYSTEM

FDA Adverse Event
Malfunction ·INSULET CORPORATION·Product code LZG·October 3, 2023

OMNIPOD DASH INSULIN MANAGEMENT SYSTEM

FDA Adverse Event
Death ·INSULET CORPORATION·Product code LZG·July 19, 2023

NEUROFORM 3 STENT SYSTEM

FDA Adverse Event
Injury ·NEUROVASCULAR DIVISION, BOSTON SCIENTIFIC CORP·Product code NJE·October 23, 2008

ONETOUCHPING GLUCOSEMGMTSYSTEM

FDA Adverse Event
Malfunction ·ANIMAS CORPORATION·Product code LZG·August 15, 2011

2124215-2013-09993

FDA Adverse Event
Malfunction ·GUIDANT PUERTO RICO BV·Product code NVY·July 8, 2013

OMNIPOD DASH INSULIN MANAGEMENT SYSTEM

FDA Adverse Event
Malfunction ·INSULET CORPORATION·Product code LZG·December 13, 2023

OMNIPOD DASH, PODS 10-PACK

FDA Adverse Event
Malfunction ·INSULET CORPORATION·Product code LZG·May 9, 2023

OMNIPOD INSULIN MANAGEMENT SYSTEM

FDA Adverse Event
Injury ·INSULET CORPORATION·Product code LZG·January 23, 2024

OMNIPOD DASH¿ INSULIN MANAGEMENT SYSTEM

FDA Adverse Event
Injury ·INSULET CORPORATION·Product code LZG·July 21, 2022

OMNIPOD 5 POD

FDA Adverse Event
Injury ·INSULET CORPORATION·Product code QFG·July 11, 2023

OMNIPOD DASH INSULIN MANAGEMENT SYSTEM

FDA Adverse Event
Injury ·INSULET CORPORATION·Product code LZG·April 17, 2023

StimQ Peripheral Nerve Stimulator System (PNS) Models: 1. FR4A-TRL-BO US and 2. FR4A-TR-BO - Product Usage: is used for peripheral neural stimulation to provide therapeutic relief for chronic, intractable pain of peripheral nerve origin. The therapy utilizes pulsed electrical current to create an electrical energy field that acts on peripheral nerves in the limbs and torso to alter the transmission of pain signals to the brain.

FDA Enforcement
Class II ·Ongoing·Stimwave Technologies Inc·September 9, 2020